Literature DB >> 24592666

Kratom abuse in Ramathibodi Poison Center, Thailand: a five-year experience.

Satariya Trakulsrichai1, Achara Tongpo2, Charuwan Sriapha2, Sunun Wongvisawakorn2, Panee Rittilert2, Sming Kaojarern2, Winai Wananukul2.   

Abstract

Kratom (Mitragyna speciosa Korth), a native tree in Southeast Asia, is misused as an abuse drug and becomes legally widespread to several countries. Currently, it is available through the online market or by some shops. The clinical manifestations of Kratom's effects are not well-defined and the clinical studies are limited. This study was designed to identify the characteristics of Kratom poisoning and withdrawal cases from Kratom exposure cases in Ramathibodi Poison Center (RPC), Thailand, during a five-year period. We used a retrospective review of Kratom exposure cases from the RPC toxic surveillance system. A total of 52 Kratom exposure cases were identified. The trend of case consultations has been increasing. There were Kratom poisoning cases (76.9%) and withdrawal cases (23.1%). Common presenting symptoms in the poisoning group were palpitation (22.5%), followed by seizure (17.5%). For the withdrawal group, the common presenting symptoms were myalgia (33.3%), insomnia (16.67%), fatigue (16.67%), and chest discomfort (16.67%). There was a baby with withdrawal symptoms who was delivered from a chronic Kratom-abusing mother, suggesting possible exposure via the transplacental route. There were no deaths in either group. Kratom abuse can cause either poisoning or withdrawal. Most cases in both groups had good prognostic outcome.

Entities:  

Mesh:

Year:  2013        PMID: 24592666     DOI: 10.1080/02791072.2013.844532

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  11 in total

1.  Novel case of maternal and neonatal kratom dependence and withdrawal.

Authors:  Lindsay Mackay; Ronald Abrahams
Journal:  Can Fam Physician       Date:  2018-02       Impact factor: 3.275

2.  Cardiac arrest in a young healthy male patient secondary to kratom ingestion: is this 'legal high' substance more dangerous than initially thought ?

Authors:  Hafez Mohammad Ammar Abdullah; Iqra Haq; Randall Lamfers
Journal:  BMJ Case Rep       Date:  2019-07-19

Review 3.  Breakthrough Seizure Associated With Kratom Use in Patients With Epilepsy.

Authors:  Devin J Burke; Sarah G Mahonski; Anne C Van Cott
Journal:  Neurol Clin Pract       Date:  2021-02

Review 4.  Kratom (Mitragyna Speciosa) Liver Injury: A Comprehensive Review.

Authors:  Jonathan Schimmel; Richard C Dart
Journal:  Drugs       Date:  2020-02       Impact factor: 11.431

5.  Pharmacokinetics of mitragynine in man.

Authors:  Satariya Trakulsrichai; Korbtham Sathirakul; Saranya Auparakkitanon; Jatupon Krongvorakul; Jetjamnong Sueajai; Nantida Noumjad; Chonlaphat Sukasem; Winai Wananukul
Journal:  Drug Des Devel Ther       Date:  2015-04-29       Impact factor: 4.162

6.  Kratom, an Emerging Drug of Abuse, Raises Prolactin and Causes Secondary Hypogonadism: Case Report.

Authors:  Lauren LaBryer; Rohan Sharma; Kaustubh Suresh Chaudhari; Mitali Talsania; Robert Hal Scofield
Journal:  J Investig Med High Impact Case Rep       Date:  2018-03-16

Review 7.  Novel Psychoactive Substances-Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs.

Authors:  Zurina Hassan; Oliver G Bosch; Darshan Singh; Suresh Narayanan; B Vicknasingam Kasinather; Erich Seifritz; Johannes Kornhuber; Boris B Quednow; Christian P Müller
Journal:  Front Psychiatry       Date:  2017-08-18       Impact factor: 4.157

8.  Recurrent seizures from chronic kratom use, an atypical herbal opioid.

Authors:  William O Tatum; Tasneem F Hasan; Erin E Coonan; Christopher P Smelick
Journal:  Epilepsy Behav Case Rep       Date:  2018-04-17

9.  The pattern of substance abuse in Thai elderly: Ramathibodi Poison Center.

Authors:  Sirasa Ruangritchankul; Sahaphume Srisuma
Journal:  SAGE Open Med       Date:  2019-08-30

10.  Kratom policy: The challenge of balancing therapeutic potential with public safety.

Authors:  Walter C Prozialeck; Bonnie A Avery; Edward W Boyer; Oliver Grundmann; Jack E Henningfield; Andrew C Kruegel; Lance R McMahon; Christopher R McCurdy; Marc T Swogger; Charles A Veltri; Darshan Singh
Journal:  Int J Drug Policy       Date:  2019-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.